Skip to main content
. 2020 May 15;10:763. doi: 10.3389/fonc.2020.00763

Table 4.

Major GEC ICI trials.

Name of trial Tumor subtype Line of Rx PD-L1 IHC selection PD-L1 IHC stratification References
ATTRACION-2 GC ≥3 No No (35)
KEYNOTE-059
Cohort 1
GC ≥3 No NA (non randomized) (36)
JAVELIN-300 GC ≥3 No No (23)
KEYNOTE-061 GC 2 No (first 83%)
CPS ≥ 1 (last 17%)
Yes (CPS ≥ 1) (25)
KEYNOTE-062 GC 1 CPS ≥ 1 No (28)
JAVELIN-100 GC 1 No No (28)
KEYNOTE-181 EC 2 No No (15)
ATTRACTION-3 ESCC 2 No No (41)
KEYNOTE-180 EC ≥3 No NA (non randomized) (39)